CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I, Open Label Study Investigating the Disposition of 25 mg/m² [14C]-AVE8062 (1.85 MBq, 50 µCi) Administered at Cycle 1 as a 30-minute Intravenous Infusion to Patients With Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01063946
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:14.384188+00:00
Published At: 2011-12-21T00:00:00+00:00
Record Updated At: 2011-12-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoplasms, Malignant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-12-21"
protocolSection.identificationModule.nctId: "NCT01063946"
protocolSection.identificationModule.officialTitle: "A Phase I, Open Label Study Investigating the Disposition of 25 mg/m\u00b2 [14C]-AVE8062 (1.85 MBq, 50 \u00b5Ci) Administered at Cycle 1 as a 30-minute Intravenous Infusion to Patients With Advanced Solid Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.